Published in Arch Int Pharmacodyn Ther on August 01, 1978
Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br J Pharmacol (1985) 0.97
Adenosine, adenosine receptors and their role in glucose homeostasis and lipid metabolism. J Cell Physiol (2013) 0.81
[Effectiveness of fixed analgesic combinations exemplified by thomapyrin]. Wien Klin Wochenschr (1996) 2.03
[The basics of catecholamine therapy. 2. A guide to clinical use]. Anasthesiol Intensivmed Notfallmed Schmerzther (2000) 1.43
Different sites of adenosine formation in the heart. Am J Physiol (1981) 1.39
Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem (1997) 1.30
Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart. Biochem J (1981) 1.14
Pelvic urine composition as a determinant of inner medullary solute concentration and urine osmolarity. Pflugers Arch (1972) 1.13
Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Eur J Pharmacol (1982) 1.09
Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol (1995) 1.09
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
The effects of starvation and of acute and chronic alloxan diabetes on myocardial substrate levels and on liver glycogen in the rat in vivo. Eur J Biochem (1967) 1.07
Perioperative risk of bradyarrhythmias in patients with asymptomatic chronic bifascicular block or left bundle branch block: does an additional first-degree atrioventricular block make any difference? Anesthesiology (1998) 1.02
Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.00
[Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses]. Arzneimittelforschung (1966) 0.99
Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci U S A (1991) 0.98
Perioperative transcutaneous pacemaker in patients with chronic bifascicular block or left bundle branch block and additional first-degree atrioventricular block. Acta Anaesthesiol Scand (1999) 0.98
Coronary dilatory action of adenosine analogues: a comparative study. Arch Int Pharmacodyn Ther (1977) 0.96
Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Int J Cardiol (1987) 0.95
The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.94
Interactions of the bovine brain A1-adenosine receptor with recombinant G protein alpha-subunits. Selectivity for rGi alpha-3. J Biol Chem (1991) 0.94
Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding. Biochem J (1991) 0.93
Use of multi-plane transoesophageal echocardiography in visualization of the main hepatic veins and acquisition of Doppler sonography curves. Comparison with the transabdominal approach. Br J Anaesth (2001) 0.92
Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg (1988) 0.92
Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.91
[Effect of Aminorex (Manocil) on hemodynamics of the pulmonary and systemic circulation during intravenous administration in dogs]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.90
Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol (1981) 0.88
Glomeruli and microvessels of the rabbit kidney contain both A1- and A2-adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.87
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. J Neurochem (1992) 0.87
NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. Drug Metab Dispos (1993) 0.87
Enhancement of the coronary dilator effect of intravenous and intracoronary administered adenosine by hexobendine in dogs. Eur J Pharmacol (1971) 0.87
Assessment of changes in vasomotor tone in vivo using intravascular ultrasound. J Pharmacol Toxicol Methods (1992) 0.86
Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs. Br J Pharmacol (1988) 0.86
P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex. Br J Pharmacol (1990) 0.86
[Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents]. Arzneimittelforschung (1968) 0.86
The effects of adenosine on coronary conductance, cardiac dynamics and myocardial metabolism of the isolated perfused cat heart. Pharmacology (1974) 0.85
Can exercise-induced regional contractile dysfunction be prevented by selective bradycardic agents? Naunyn Schmiedebergs Arch Pharmacol (1986) 0.85
The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and on myocardial metabolism in dogs. Pflugers Arch (1970) 0.85
Catecholamine excretion and heart rate as factors of psychophysical stress in table tennis. Int J Sports Med (1992) 0.84
Effect of aminophylline on coronary reactive hyperaemia following brief and long occlusion periods. Cardiovasc Res (1977) 0.84
The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J Biol Chem (1997) 0.84
l-NG-nitro-arginine methyl ester in the anesthetized rabbit: venous vasomotion and plasma levels. J Vasc Res (1992) 0.84
Pulmonary and systemic circulatory effects and -adrenergic selectivity of hexoprenaline, salbutamol, oxyfedrine, and isoproterenol. Eur J Pharmacol (1971) 0.83
Cardiac ventricular beta 2-adrenoceptors in guinea-pigs and rats are localized on the coronary endothelium. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
A model of transient myocardial dysfunction in conscious dogs. Regional shortening in the presence of impaired coronary flow reserve and treadmill exercise. J Pharmacol Methods (1986) 0.83
Evidence for glucagon-releasing activity of vasoactive adenosine analogues in the conscious dog. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.83
Effects of exercise on circulating vascular adhesion molecules in healthy men. Immunobiology (1997) 0.83
The effects of NECA (adenosine-5'N-ethylcarboxamide) and of adenosine on glucagon and insulin release from the in situ isolated blood-perfused pancreas in anesthetized dogs. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
Characterization of angiotensin-II effects on cerebral and ocular circulation by noninvasive methods. Br J Clin Pharmacol (1997) 0.82
Role of nitric oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol (1995) 0.82
The effects of intra-arterial adenosine infusion on substrate levels and blood flow in skeletal muscle of the dog. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J Cardiovasc Pharmacol (1989) 0.82
Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours. Clin Chem Lab Med (1998) 0.82
Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay. Biochem J (1984) 0.82
High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem J (1996) 0.81
2',3'-Dialdehyde GTP as an irreversible G protein antagonist. Disruption and reconstitution of G protein-mediated signal transduction in cells and cell membranes. J Biol Chem (1994) 0.81
[Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs]. Arzneimittelforschung (1973) 0.81
Relaxation of coronary artery strips by adenosine and acidosis. Eur J Pharmacol (1977) 0.81
Effects of alinidine on exercise-induced regional contractile dysfunction in dogs. Eur J Pharmacol (1986) 0.81
Effects of ischemia on the canine myocardial beta-adrenoceptor-linked adenylate cyclase system. J Cardiovasc Pharmacol (1987) 0.81
Function of the autonomic nervous system in young, untreated hypertensive patients. Int J Cardiol (1986) 0.80
A comparison of the effects of hexobendine with those of anoxia on the concentration of myocardial metabolites in vivo. Eur J Pharmacol (1967) 0.80
Effect of a 5'-substituted adenosine analogue (744c96) on insulin and glucagon release in isolated rat islets of Langerhans. Arch Int Pharmacodyn Ther (1979) 0.80
Antihypertensive effects of niguldipine-HCl (B 844-39), a new calcium antagonist in dogs. J Cardiovasc Pharmacol (1987) 0.80
Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methylester in canine blood in vitro. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.80
Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level. Prostaglandins (1988) 0.80
Mode of QT correction for heart rate: implications for the detection of inhomogeneous repolarization after myocardial infarction. Am Heart J (1992) 0.80
Fentanyl inhibits the canine carotid chemoreceptor reflex. Anesth Analg (1989) 0.80
Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium. J Cardiovasc Pharmacol (1985) 0.80
The myocardial oxaloacetate level in normal and chronic alloxan-diabetic rats in vivo. J Mol Cell Cardiol (1972) 0.79
Alterations of the glomerular beta-adrenoceptor-linked adenylate cyclase system in perinephritis hypertension. J Cardiovasc Pharmacol (1986) 0.79
Propranolol ameliorates exercise-induced regional myocardial dysfunction in dogs. Clin Exp Pharmacol Physiol (1987) 0.79
[Memantine and neurogenic bladder disorders within the bounds of spastic conditions]. Arzneimittelforschung (1982) 0.79
Blockade of endothelium-derived relaxing factor synthesis with NG-nitro-L-arginine methyl ester leads to enhanced venous reactivity in vivo. Eur J Pharmacol (1992) 0.79
Binding of [3H]ouabain to endothelial cells derived from various vascular beds. Basic Res Cardiol (1988) 0.79
Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. Can J Physiol Pharmacol (1996) 0.79
Pheochromocytoma of the urinary bladder--a case report and review of the literature. Urol Int (1984) 0.79
[Effects of morphine on the control of the cardiovascular system by the carotid-sinus-reflex and by the carotid chemoreflex]. Anaesthesist (1983) 0.79
Age-related changes in vascular reactivity in genetically diabetic rats. Pharmacology (1995) 0.79
The determination of the myocardial extracellular space in the cat in vivo: a comparative methodological study. Basic Res Cardiol (1976) 0.79
Esmolol: effects on isoprenaline- and exercise-induced cardiovascular stimulation in conscious dogs. Can J Physiol Pharmacol (1990) 0.79
The Erlanger Microlightguide Photometer: a new concept for monitoring intracapillary oxygen supply of tissue--first results and a review of the physiological basis. J Clin Monit (1996) 0.78
The influence of dihydroergotamine on adenosine-induced and reactive coronary vasodilation. Interaction of dihydroergotamine and coronary vasodilation. Basic Res Cardiol (1977) 0.78